title: [Immunosuppressive therapies for refractory nephrotic syndrome].
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Mitarai
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D001379:Azathioprine / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D016572:Cyclosporine / Q000008:administration & dosage; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics; D016903:Drug Monitoring; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives; D009404:Nephrotic Syndrome / Q000188:drug therapy*; D011110:Polymorphism, Genetic; D012263:Ribonucleosides / Q000008:administration & dosage; D000069283:Rituximab; D016559:Tacrolimus / Q000008:administration & dosage
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D012263:Ribonucleosides; D000069283:Rituximab; C010052:mizoribine; D016572:Cyclosporine; D003520:Cyclophosphamide; D003577:Cytochrome P-450 Enzyme System; D009173:Mycophenolic Acid; D001379:Azathioprine; D016559:Tacrolimus